[HTML][HTML] Efficacy and safety of an extravascular implantable cardioverter–defibrillator
P Friedman, F Murgatroyd, LVA Boersma… - … England Journal of …, 2022 - Mass Medical Soc
Background The extravascular implantable cardioverter–defibrillator (ICD) has a single lead
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …
implanted substernally to enable pause-prevention pacing, antitachycardia pacing, and …
The development of the extravascular defibrillator with substernal lead placement: A new Frontier for device‐based treatment of sudden cardiac arrest
AE Thompson, B Atwater, L Boersma… - Journal of …, 2022 - Wiley Online Library
Introduction The extravascular implantable cardioverter‐defibrillator (EV ICD) system with
substernal lead placement is a novel nontransvenous alternative to current commercially …
substernal lead placement is a novel nontransvenous alternative to current commercially …
Efficacy and safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in …
RE Knops, W Van Der Stuijt, PPHM Delnoy… - Circulation, 2022 - Am Heart Assoc
Background: The PRAETORIAN trial (A Prospective, Randomized Comparison of
Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) showed …
Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) showed …
[HTML][HTML] Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable …
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) has
demonstrated safety and efficacy for the treatment of malignant ventricular arrhythmias …
demonstrated safety and efficacy for the treatment of malignant ventricular arrhythmias …
EHRA White Paper: knowledge gaps in arrhythmia management—status 2019
A Goette, A Auricchio, G Boriani, F Braunschweig… - EP …, 2019 - academic.oup.com
Clinicians accept that there are many unknowns when we make diagnostic and therapeutic
decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside …
decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside …
Competitive athletes with implantable cardioverter–defibrillators—How to program? Data from the Implantable Cardioverter–Defibrillator Sports Registry
B Olshansky, G Atteya, D Cannom, H Heidbuchel… - Heart Rhythm, 2019 - Elsevier
Background Athletes with an implantable cardioverter–defibrillator (ICD) may require unique
optimal device-based tachycardia programming. Objective The purpose of this study was to …
optimal device-based tachycardia programming. Objective The purpose of this study was to …
[HTML][HTML] Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling
Background Antitachycardia pacing (ATP) success rates as low as 50% for fast ventricular
tachycardias (VTs) have been reported providing an opportunity for improved ATP to …
tachycardias (VTs) have been reported providing an opportunity for improved ATP to …
[HTML][HTML] Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics
LD Sterns, A Auricchio, EJ Schloss, D Lexcen… - Heart Rhythm, 2023 - Elsevier
Background Antitachycardia pacing (ATP) is an established implantable cardioverter-
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …
[HTML][HTML] Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: results …
C Schuger, JP Daubert, W Zareba, S Rosero, P Yong… - Heart Rhythm, 2021 - Elsevier
Background In Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate
Therapy (MADIT-RIT), high-rate cutoff (arm B) and delayed therapy (arm C) reduced the risk …
Therapy (MADIT-RIT), high-rate cutoff (arm B) and delayed therapy (arm C) reduced the risk …
Initial clinical experience with a new automated antitachycardia pacing algorithm: feasibility and safety in an ambulatory patient cohort
R Yee, JD Fisher, U Birgersdotter-Green… - Circulation …, 2017 - Am Heart Assoc
Background: Antitachycardia pacing (ATP) in implantable cardioverter-defibrillators (ICD)
decreases patient shock burden but has recognized limitations. A new automated ATP …
decreases patient shock burden but has recognized limitations. A new automated ATP …